Biotech · Private company
Bionomics Limited
Track this companyFree. Adds Bionomics Limited to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 225 mg BNC210Phase 3 · Social Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- 675 mg BNC210Phase 2 · Social Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- BNC210Phase 2 · Post-Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1PHASE3 · COMPLETED · started Aug 6, 2024ClinicalTrials.gov NCT06510504 · fetched Nov 12, 2026
- A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety DisorderPHASE2 · COMPLETED · started Feb 2, 2022ClinicalTrials.gov NCT05193409 · fetched Nov 12, 2026
- A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)PHASE2 · COMPLETED · started Jul 27, 2021ClinicalTrials.gov NCT04951076 · fetched Nov 12, 2026
- Phase II Study of BNC210 in PTSDPHASE2 · COMPLETED · started Jun 30, 2016ClinicalTrials.gov NCT02933606 · fetched Nov 12, 2026
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell CarcinomaPHASE1_PHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01034631 · fetched Nov 12, 2026